Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus
- 1 May 1995
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 98 (5), 443-451
- https://doi.org/10.1016/s0002-9343(99)80343-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Epidemiology of Proliferative Diabetic RetinopathyDiabetes Care, 1992
- Sulfonylureas Why, Which, and How?Diabetes Care, 1990
- Oral Hypoglycemic AgentsNew England Journal of Medicine, 1989
- Weight Gain Associated With Intensive Therapy in the Diabetes Control and Complications TrialDiabetes Care, 1988
- AcarboseDrugs, 1988
- EFFECT OF TWO YEARS OF STRICT METABOLIC CONTROL ON PROGRESSION OF INCIPIENT NEPHROPATHY IN INSULIN-DEPENDENT DIABETESThe Lancet, 1986
- PREVENTION OF DETERIORATION OF RENAL AND SENSORY-NERVE FUNCTION BY MORE INTENSIVE MANAGEMENT OF INSULIN-DEPENDENT DIABETIC PATIENTSThe Lancet, 1983
- DEVELOPMENT OF RETINOPATHY AND PROTEINURIA IN RELATION TO PLASMA-GLUCOSE CONCENTRATIONS IN PIMA INDIANSThe Lancet, 1980
- Amelioration of Mesangial Volume and Surface Alterations Following Islet Transplantation in Diabetic RatsDiabetes, 1980
- HYPERGLYCÆMIA AND DIABETES MELLITUSThe Lancet, 1976